Previous Article | Next Article ![]()
Infection and Immunity, December 2003, p. 7023-7034, Vol. 71, No. 12
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.12.7023-7034.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Infectious Diseases and Microbiology, Graduate School of Public Health,1 Department of Molecular Genetics and Biochemistry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania2
Received 25 April 2003/ Returned for modification 17 June 2003/ Accepted 20 August 2003
| ABSTRACT |
|---|
|
|
|---|
)-inducible chemokine mRNAs (CXCL9/monokine induced by
IFN-
, CXCL10/IFN-
-inducible protein, and
CXCL11/IFN-
-inducible T-cell
-chemoattractant) within
solid and caseous granulomas, and there was only minimal expression in
nongranulomatous regions of tissue. The mRNA expression patterns of
IFN-
and tumor necrosis factor alpha were examined in
parallel, and the results revealed that cytokine
mRNA+ cells were abundant and generally localized to
the granulomas. Mycobacterial 16S rRNA expression was also measured by
ISH, and the results revealed that there was localization predominantly
to the granulomas and that the highest signal intensity was in caseous
granulomas. We observed several granulomatous lesions with
exceptionally high levels of RNA for mycobacterial 16S rRNA,
IFN-
, and IFN-
-inducible chemokines, suggesting that
the local presence of mycobacteria is partially responsible for the
upregulation of IFN-
-inducible chemokines and recruitment of
CXCR3+ cells, which were also abundant in
granulomatous lesions. These results suggest that expression of CXCR3
ligands and the subsequent recruitment of CXCR3+
cells are involved in granuloma formation and
maintenance. | INTRODUCTION |
|---|
|
|
|---|
Granulomas are hallmarks of chronic infectious diseases, such as tuberculosis, brucellosis, and schistosomiasis, and also develop due to the presence of allergens and metals. The granulomatous lesions are generally considered to be the result of chronic antigenic stimulation (10, 36). A tuberculous granuloma is a focal collection of mononuclear cells surrounded by a halo of lymphocytes and additional monocytes (36, 40, 41, 49, 53). The reaction occurs when an infected macrophage becomes encircled by other macrophages and the immune system attempts to wall off the microorganisms to prevent the bacteria from spreading locally and throughout the body. This complex cellular structure can be surrounded by connective tissue, including fibroblasts, collagen fibers, and newly formed vessels (36). A novel morphological characteristic of the granuloma is the presence of epithelioid cells, which occupy the center of each lesion. These epithelioid cells are activated macrophages, which contain increased cytoplasm and disperse chromatin resembling epithelial cells (36). Langhans multinucleated giant cells are also found in granulomas.
M.
tuberculosis induces a proinflammatory immune response that is
characterized by expression of gamma interferon (IFN-
), tumor
necrosis factor alpha (TNF-
), and interleukin-12 (IL-12)
(12,
14,
30-32,
45,
53,
56,
57). Although information
has been obtained from bronchoalveolar lavages (BAL) and lung biopsies
during advanced disease in humans, only a small number of studies have
examined the local cytokine expression patterns associated specifically
with granulomas. Examination of BAL cells has indicated that M.
tuberculosis induces a type 1 polarized cytokine response
characterized by IFN-
expression
(4,
8,
50,
55). However, when
Fenhalls et al. studied pulmonary granulomas from individuals with
active tuberculosis, they found that the expression patterns of
IFN-
relative to those of IL-4 were highly associated with the
type of granuloma formed
(23). Granulomas with no
evidence of caseation expressed either IFN-
mRNA or
IFN-
mRNA plus IL-4 mRNA, whereas caseous granulomas expressed
little IFN-
mRNA or IL-4 mRNA
(23). These findings
suggest that these cytokines play a role in determining granuloma
architecture.
The development of a granuloma likely depends on
the movement of cells toward the site of inflammation due to expression
of chemotactic molecules, although only one study to date has examined
local chemokine expression directly in granulomatous tissue sections
(24). Proinflammatory
chemokines are chemotactic cytokines which play a major role in the
recruitment of receptor-bearing cells to sites of inflammation
(2,
35). The functions of
chemokines include chemotaxis, integrin activation, and degranulation
of distinct leukocyte subsets expressing specific chemokine receptors
(17). The expression of
proinflammatory chemokines is induced by local environmental signals,
such as TNF-
or IFN-
(2,
48). Granulomas induced
experimentally with mycobacterial agents lead to the development of
type 1 cytokine and chemokine expression profiles
(12,
14,
45). IFN-
induces macrophages and dendritic cells (DC) to produce
IFN-
-inducible CXCR3 ligands, CXCL9/monokine induced by
IFN-
(Mig), CXCL10/IFN-
-inducible protein with a size
of 10 kDa (IP-10), and CXCL11/IFN-
-inducible T-cell
-chemoattractant (I-TAC), which recruit
CXCR3+ cells
(52).
CXCR3+ cells typically express type 1 cytokines
(18) and therefore can
potentially induce further upregulation of CXCR3 ligands, leading to
chronic type 1 polarized inflammation, which occurs during simian
immunodeficiency virus (SIV) infection of rhesus macaques (Macaca
mulatta)
(46).
The local
chemokine expression patterns in granulomatous tissues have not been
fully examined directly in tissue sections thus far. Experimental
M. tuberculosis infection in a macaque model induces granuloma
formation remarkably similar to that seen in humans infected with this
pathogen (11,
34,
62). In this study, we
examined the chemokine and cytokine mRNA expression patterns in lung
tissues from M. tuberculosis-infected cynomolgus macaques
(Macaca fascicularis) by in situ hybridization (ISH). Our
results provide direct evidence that IFN-
mRNA is present and
abundant in the granulomas of infected cynomolgus macaques and that
IFN-
-inducible chemokine mRNAs are upregulated and potentially
responsible for the recruitment of CXCR3+ cells that
could further skew the immune environment through ongoing IFN-
production. The abundant expression of IFN-
-inducible CXCR3
ligands and the inflammatory cytokines IFN-
and TNF-
directly in solid and caseous granulomas suggests that continual cell
recruitment and a state of chronic inflammation likely contribute to
the formation and maintenance of tuberculous
granulomas.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Immunohistochemistry. Immunohistochemical staining of 14-µm tissue sections was performed by using cell-type-specific antibodies, including anti-CD3 (clone CD3-12; NovoCastra), anti-CD68 (clone KP1; Dako), anti-CD20 (clone L26; Dako), and anti-CXCR3 (clone 1C6; Pharmingen). Tissue sections were pretreated in 0.01 M sodium citrate (pH 6.0) by microwaving, followed by application of the primary antibody (diluted in 1x phosphate-buffered saline) to the tissues for 1 h in a humid chamber at room temperature. Primary antibodies were detected with the PicTure-Plus detection system (Zymed Laboratories) by using 3,3'-diaminobenzidine as the final substrate.
ISH.
Riboprobe synthesis and ISH were
performed on 14-µm tissue sections as previously described
(15,
20,
46). Cytokine and
chemokine mRNAs were detected by ISH by using gene-specific riboprobes.
Plasmids containing macaque IFN-
and TNF-
cDNAs were
kindly provided by Francois Villinger (Emory University). Plasmids
encoding CXCL9/Mig, CXCL10/IP-10, and CXCL11/I-TAC genes have been
described previously (5,
46). The autoradiographic
exposure times were 7, 10, and 11 days for chemokine mRNA ISH, cytokine
mRNA ISH, and M. tuberculosis 16S rRNA ISH,
respectively.
Quantitative image capture and analysis. Each granuloma present in lung tissue sections was categorized as a solid or caseous granuloma. ISH signal intensities were measured by quantitative image analysis. Using an RT Slider Spot camera (Diagnostic Instruments, Inc.), we captured images of all granulomas with a x4 objective lens. The MetaView software package (Universal Imaging Corp.) was used to measure the surface area covered by autoradiographic silver grains, as well as the total surface area of the granuloma. After color separation, the green channel was converted to pseudocolor, and the image was thresholded to measure the surface area covered by silver grains.
M. tuberculosis 16S rRNA subcloning and sequencing. The 16S ribosomal DNA from M. tuberculosis strain H37Rv was amplified by PCR by using sequence-specific forward primer 5'-GGCGTGCTTAACACATGCAA-3' and reverse primer 5'-CGCTCACAGTTAAGCCGT-3', as previously described (43). The amplified product (550 bp) was subcloned into pGEMT, and the DNA was sequenced, which revealed 100% homology to 16S rRNA genes of both the H37Rv and CDC1551 strains of M. tuberculosis (data not shown).
| RESULTS |
|---|
|
|
|---|
|
|
-inducible CXCR3 ligands in granulomatous
lesions.
Chemokines likely
play multiple roles in M. tuberculosis-associated granuloma
formation and maintenance, including shaping of the local immune
environment. Since IFN-
is a cytokine that is critical for
host resistance to M. tuberculosis disease progression in mice
and humans (16,
25,
29,
39), we determined the
patterns and levels of expression of mRNAs encoding the
IFN-
-inducible chemokines CXCL9/Mig, CXCL10/IP-10, and
CXCL11/I-TAC directly in lung tissues from experimentally infected
macaques. This approach can reveal changes in mRNA expression levels
that might not be as evident if RNAs from homogenized tissues are used
in population analyses. ISH of these CXCR3 ligand mRNAs revealed
extremely abundant expression within the granulomatous lesions; the
highest signal was observed for CXCL9/Mig and the lowest signal was
observed for CXCL11/I-TAC in both solid and caseous granulomas (Fig.
2). In contrast, nongranulomatous regions of lung tissue and lung tissue
from M. tuberculosis-naïve control macaques rarely
exhibited appreciable expression of any CXCR3 ligand mRNA (Fig.
2) (data not shown). Solid
granulomas had intense ISH signals concentrated only in the central
portions of the granulomas, whereas caseous granulomas had intense ISH
signals concentrated in the cellular portions of the granulomas
surrounding the acellular centers (Fig.
2).
|
-inducible chemokines were dramatically upregulated in
macaque pulmonary granulomatous lesions compared to the levels in
nongranulomatous tissue and naïve controls.
|
|
Expression of IFN-
and
TNF-
mRNAs is elevated in granulomatous lesions.
Previous studies have shown that
IFN-
plays a protective role in the host response to M.
tuberculosis, that TNF-
is important in granuloma
formation and maintenance
(6,
9,
13,
48), and that both
cytokines can induce expression of subsets of chemokines
(2,
48). Therefore, we
examined the patterns and levels of expression of the mRNAs of these
cytokines in M. tuberculosis-induced granulomatous lesions in
cynomolgus macaques. TNF-
and IFN-
mRNA+ cells were abundant in the
granulomatous lesions of these macaques (Fig.
2I to L) but were
extremely rare in nongranulomatous regions of lung tissue sections.
These TNF-
and IFN-
mRNA+ cells
were found in the cellular regions of granulomas and colocalized with
the IFN-
-inducible chemokine ISH signal (Fig.
2C to H). In contrast, no
IL-4 mRNA+ cells were observed in any of the same
tissue sections (data not shown). As a measure of local cytokine mRNA
expression, we manually counted the cytokine mRNA+
cells in each granuloma. An ISH signal for IFN-
mRNA was
present as a dense focal collection of silver grains (Fig.
2I and J), whereas an ISH
signal for TNF-
mRNA was present as networks of more diffuse
signal (Fig. 2K and L).
The number of IFN-
mRNA+ cells per
14-µm granuloma section was greater than the number of
TNF-
mRNA+ cells in both groups of animals
(Fig. 3B and Table
2), and caseous granulomas
harbored higher numbers of IFN-
mRNA+ cells
per granuloma than solid granulomas harbored (Fig.
3B and Table
2). The average numbers of
IFN-
mRNA+ cells were 24 and 52
mRNA+ cells per 14-µm section of granuloma
for solid and caseous granulomas, respectively (Table
2), whereas the average
numbers of TNF-
mRNA+ cells were 14 and 27
mRNA+ cells per section of granuloma for solid and
caseous granulomas, respectively. However, the mean values in Table
2 indicate that the
numbers of IFN-
mRNA+ cells present in the
cellular regions of granulomas were roughly proportional to granuloma
size.
Detection and quantitation of M.
tuberculosis 16S rRNA in pulmonary granulomatous
lesions.
The high levels of
chemokine and cytokine mRNA expression which we observed in
granulomatous lesions might have been associated with high numbers of
local mycobacteria or mycobacterial products. To address this
possibility, we performed ISH using a riboprobe specific for
mycobacterial 16S rRNA. ISH with this riboprobe readily allowed
detection of the mycobacterial 16S rRNA in lung tissue sections of
cynomolgus macaques (Fig.
4). No specific ISH signal was detected in the corresponding sense control
probe experiments (Fig.
4E, inset). The ISH signal
observed was typically a compact collection of silver grains or, more
rarely, a more diffuse collection of silver grains scattered over an
entire lung cell. We based our enumeration of the mycobacterial 16S
rRNA+ focal collections on the assumption that a
focus represented either a single bacterium or a collection of bacteria
that could not be individually distinguished. Although mycobacterial
16S rRNA+ foci were detected in both solid (Fig.
4A) and caseous (Fig.
4B) granulomas, they were
more abundant in the caseous granulomas, and they were also more
abundant in the macaques with advanced disease than in the macaques
with minimal or moderate disease. The mycobacterial 16S
rRNA+ focal collections were observed in both the
cellular regions and the central caseating portions of granulomas.
Frequently, 16S rRNA+ focal collections were in
close proximity to each other in cellular regions of granulomas, but
the greatest ISH signals were observed in the acellular centers of
caseous granulomas. In animal M11301 with advanced disease, 1,820 16S
rRNA+ foci were detected in a single 14-µm
section of an exceptional granuloma (Fig.
4C). If we assumed that
this entire granuloma was spherical and that the tissue section
represented the largest diameter of the granuloma, the entire granuloma
(2.5 x 1010 µm3) was estimated to
harbor a minimum of 303,394 mycobacteria. The IFN-
mRNA ISH
signal obtained in a subjacent section of the same granuloma was
extremely high (Fig. 4D),
as were the intense ISH signals for TNF-
and CXCR3 ligand
mRNAs (data not shown).
|
mRNA was also exceptionally abundant (Fig.
4F), and the ISH signal
colocalized with the 16S rRNA+ foci. CXCR3 ligand
mRNA expression was similarly abundant in this cavitating lesion (data
not shown). | DISCUSSION |
|---|
|
|
|---|
and TNF-
, as well as
IFN-
-inducible CXCR3 ligands, within all granulomas regardless
of size or structure. The general absence of cells expressing these
mRNAs in nongranulomatous regions of lung tissues
suggests that they play a local role in granuloma formation and
maintenance. Based on these findings we propose a model for M.
tuberculosis-initiated, IFN-
-driven chronic inflammation
in pulmonary granulomas that is similar to a model for the events
occurring in lymphoid tissues of SIV-infected rhesus macaques
(46). Cynomolgus macaques are susceptible to M. tuberculosis infection and develop disease that is clinically, immunologically, and pathologically similar to human disease (11, 34, 62). Interestingly, approximately 40% of cynomolgus macaques infected with a low dose of M. tuberculosis were able to contain the infection in a subclinical state during the period of study. This subclinical state resembles clinical latency in humans (11, 62) and indicates that cynomolgus macaques are an appropriate animal model for latency (11, 62) and reactivation (11) during M. tuberculosis infection. Although the proportion of cynomolgus macaques that develop active disease is higher, it is similar to the outcome of infection in humans, in which only 10% of individuals infected with M. tuberculosis develop overt disease. At the tissue level, M. tuberculosis-induced granulomas in cynomolgus macaques are structurally similar to granulomas that develop in humans.
We demonstrated by direct analysis of tissue sections
using ISH that there are high levels of expression of
IFN-
-inducible chemokine mRNAs and increased numbers of
IFN-
and TNF-
mRNA+ cells in
pulmonary granulomas. CXCR3+ cells, which are
predominantly activated T and B lymphocytes and NK cells
(42,
51,
52,
54), are likely recruited
to the local environment. Our detection of abundant
CXCR3+ cells in pulmonary granulomas provides
evidence that this recruitment occurs. Although not examined here,
local proliferation and apoptosis also likely contribute to
accumulation and loss of cells, respectively, and affect overall
granuloma size and structure.
Previous studies of chemokine
expression during M. tuberculosis infection included in vivo
murine studies and ex vivo and limited tissue-based human studies. Mice
infected by the aerosol route exhibited increases in
CCL3/MIP-1
, CXCL2/MIP-2, CXCL10/IP-10, and
CCL2/MCP-1 expression in lungs
(47). In addition,
granulomas elicited in mice by purified protein derivative-coated beads
had a polarized type 1 immune response with increased levels of
expression of CXCL2/MIP-2, CXCL5/LIX, CXCL10/IP-10, and CXCL9/Mig
(14,
45). In these studies,
neutralization of IFN-
with antibodies greatly reduced the
expression of CXCL9/Mig and CXCL10/IP-10. Human studies of
patient-derived BAL or alveolar and peripheral macrophages revealed
increased expression of CXCL8/IL-8, CCL5/RANTES, CCL3/MIP-1
,
CCL2/MCP-1, and CXCL10/IP-10
(24,
53). The one other ISH
and IHC report of chemokine expression in human tuberculous granulomas
demonstrated that there was localized expression of CXCL10/IP-10,
CXCL8/IL-8, and CCL2/MCP-1 within granulomas
(24).
The strategy which we have used for detection of cells producing proinflammatory chemokines and cytokines is targeted toward mRNA expressed by the producing cell. This approach reveals the locations and numbers of cells that produce these immunomodulatory proteins, but it does not indicate the locations or amounts of actual proteins. Although this is a limitation of our study, the detection of chemokine and cytokine proteins is complicated by the diffusion of proteins that occurs after release into the extracellular milieu. The detection of different proteins by IHC is also complicated by the unique physiochemical properties of each antigen-antibody pair compared to the properties of RNA-RNA hybrids, which generally have the same physiochemical properties. Our ISH strategy has the additional advantage that it can reveal focal changes in mRNA expression that might not be detected by population analyses of extracted tissue RNAs due to dilution.
Previous in situ studies of human tuberculous
granulomas revealed local production of TNF-
and IFN-
mRNAs in all granulomatous lesions, but only a fraction of these
lesions expressed IL-4 mRNA
(23). Our data are
consistent with these findings in that IFN-
mRNA was much more
abundant than IL-4 mRNA, but they differ in that we did not detect any
IL-4 mRNA by our ISH assay, as also observed by other workers with
human granulomas (3).
Limited expression of both IFN-
and IL-4 mRNAs has been
suggested to be associated with progression of granulomas to a necrotic
state (23). However, we
observed an association between the numbers of local IFN-
and
TNF-
mRNA+ cells and the sizes (and
necrotic states) of pulmonary granulomas. The reasons for the
differences between our findings and those of other workers
(23) are not clear but
could include differences with respect to (i) the host species studied,
(ii) the disease and treatment status of the study subjects, (iii) the
tissue-processing protocols, and/or (iv) the ISH probe and detection
strategies.
Based on our finding that there was abundant
expression of CXCR3 ligands, IFN-
, and TNF-
in
pulmonary granulomatous lesions, we propose a model for the
contributions of these molecules to the chronic inflammation that
results in granuloma formation and maintenance, which is similar to a
model previously proposed for chronic inflammation in SIV-infected
lymphoid tissues (46).
First, infection of alveolar macrophages or DC leads to induction of
proinflammatory cytokines and chemokines (for example, by interaction
of mycobacterial antigen with Toll-like receptors [TLRs]).
Additional cells are therefore recruited to the local environment.
Immune responses specific to M. tuberculosis develop following
the trafficking of pulmonary DC to draining lymph nodes, which results
in the trafficking of type 1 CD4+ and
CD8+ T lymphocytes to the site of M.
tuberculosis infection, and these cells produce IFN-
.
IFN-
function is enhanced in the presence of TNF-
,
which is well documented as an important cytokine in the immune
response to M. tuberculosis and in granuloma formation
(6,
9,
13,
48). Both local
production of IFN-
and TLR stimulation induce the expression
of CXCR3 ligands and thus recruit CXCR3+ T
lymphocytes and NK cells to the site of M. tuberculosis
infection. CXCR3 ligands contribute to further polarization of the
local environment because they augment the ability of IFN-
to
induce additional CXCR3 ligand production and lead to a type 1 outcome
following stimulation of T lymphocytes with polyclonal activators or
specific antigens (28).
In this model, the collective outcome is the establishment and
maintenance of a positive feedback loop in which local IFN-
production leads to the ongoing recruitment of additional
IFN-
-producing cells. Also, this suggests that IFN-
has a role in granuloma formation and maintenance beyond induction of
an antimicrobial state in infected cells. Thus, there are common themes
in M. tuberculosis and SIV infections of macaques that, if
recapitulated in humans infected with both organisms, might contribute
to a significantly poorer prognosis than the prognosis for individuals
infected with either pathogen alone.
In addition to effects of
antigen-specific type 1 immune responses, M. tuberculosis
bacilli or mycobacterial components also have direct effects on local
cytokine and chemokine expression profiles in and near pulmonary
granulomas. In vitro analyses have demonstrated that mycobacterial cell
wall components induce expression of proinflammatory cytokines via
TLR-2 and TLR-4 (37,
58). Although alveolar
macrophages are initially involved in the uptake of M.
tuberculosis, DC and monocyte-derived interstitial macrophages
also phagocytose and process M. tuberculosis
(59). Interestingly,
Lande et al. recently demonstrated that M. tuberculosis
infection of DC leads to induction of CXCL9/Mig and CXCL10/IP-10, the
latter in an IFN-
ß-dependent fashion
(33).
In this model we have not included other complex factors, such as complex multichemokine gradients that lead to simultaneous synergistic or antagonistic signals on cells (26). In addition, there are likely to be negative regulatory activities that occur at the same time. A candidate for such regulation is the lymphocyte cell surface protein CD26 (also known as dipeptidylpeptidase IV), which catalyzes the removal of N-terminal dipeptides from suitable substrates containing a penultimate proline or alanine (60). Cleavage by CD26 differentially affects the activity of specific chemokines, rendering some chemokines inactive and others more potent (60). CD26 proteolytically processes all three CXCR3 ligands and converts them to antagonists of CXCR3-mediated chemotaxis (44). Determination of the roles played by such complex factors in granuloma formation and maintenance requires further analysis.
To determine whether the immunologic events that occur in granulomatous lesions are due to the abundance of local M. tuberculosis bacilli or products, we developed an ISH strategy for detection of mycobacterial 16S rRNA directly in tissue sections. One frequently used strategy for in situ detection of M. tuberculosis is acid-fast staining. However, the sensitivity of this procedure is reduced by the common treatment of tissues with formalin and xylene (27). Overall, we found a relatively low number of foci hybridizing to the mycobacterial 16S rRNA probe in most animals, although two animals with advanced disease had much higher levels of signal. Most of the mycobacterial 16S rRNA ISH signal was localized to the necrotic portions of the granulomas, although some signal was localized to the cellular regions of caseous and solid granulomas. Our probe for detection of M. tuberculosis does not discriminate between viable and nonviable organisms or between metabolically active and inactive states of the bacillus, but it detects an RNA target that is stable and abundant (1, 7, 61). This might explain the different localization of the M. tuberculosis ISH signal in our study compared to the localization in the studies of Fenhalls et al. (21, 22), in which the ISH signal was localized to cells in the cellular and surrounding regions of the granulomas. Once they reach a certain size or have a certain fluidic composition, the necrotic centers of caseous granulomas might provide a hospitable environment for the organism. Further studies with additional probes and tuberculosis cases and stages are needed to fully understand the importance of the numbers and states of mycobacterial organisms for granuloma formation and maintenance.
In summary,
through examination of over 300 M. tuberculosis-induced
pulmonary granulomas in experimentally infected cynomolgus macaques, we
demonstrated that there was abundant IFN-
-inducible chemokine
and IFN-
and TNF-
cytokine mRNA expression within the
granulomas. The abundant staining of CXCR3+ cells in
the same microenvironments is consistent with recruitment of these
cells to the granulomas. These findings, as well as our findings of
colocalized M. tuberculosis 16S rRNA in the pulmonary
granulomas, suggest that the nature of the type 1 immune response and
the direct action of mycobacterial components together lead to the
establishment of chronic inflammation. There must be a complex balance
among the inflammatory responses, antigen-specific responses, and
negative regulatory mechanisms that determines the extent to which a
granuloma contains the bacillus or develops into a structure that
allows the organism to multiply and spread within and among hosts.
Additional definition of the contributions of IFN-
-inducible
and other chemokines to these processes should elucidate mechanisms by
which granulomas successfully limit or eliminate M.
tuberculosis bacilli. These data should be important for
developing additional strategies to combat morbidity and mortality
caused by M. tuberculosis.
| ACKNOWLEDGMENTS |
|---|
This study was supported by NIH grant AI-47485 to J.L.F.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Alberts, B., D. Bray, J. Lewis, M. Raff, K. Roberts, and J. D. Watson. 1989. Control of gene expression, p.595 . In Molecular biology of the cell. Garland Publishing, Inc., New York, N.Y. |
| 2. | Baggiolini, M. 1998. Chemokines and leukocyte traffic.Nature 392:565-568.[CrossRef][Medline] |
| 3. | Barnes,
P. F., S. Lu, J. S. Abrams, E. Wang, M. Yamamura,
and R. L. Modlin. 1993. Cytokine production
at the site of disease in human tuberculosis. Infect.
Immun.
61:3482-3489. |
| 4. | Barry, S. M., M. C. Lipman, B. Bannister, M. A. Johnson, and G. Janossy. 2003. Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis. J. Infect. Dis. 187:243-250.[CrossRef][Medline] |
| 5. | Basu, S., T. M. Schaefer, M. Ghosh, C. L. Fuller, and T. A. Reinhart. 2002. Molecular cloning and sequencing of 25 different rhesus macaque chemokine cDNAS reveals evolutionary conservation among C, CC, CXC, and CX3C families of chemokines. Cytokine 18:140-148.[CrossRef][Medline] |
| 6. | Bean,
A. G., D. R. Roach, H. Briscoe, M. P.
France, H. Korner, J. D. Sedgwick, and W. J.
Britton. 1999. Structural deficiencies in granuloma
formation in TNF gene-targeted mice underlie the heightened
susceptibility to aerosol Mycobacterium tuberculosis
infection, which is not compensated for by lymphotoxin.J. Immunol.
162:3504-3511. |
| 7. | Belasco, J. G., G. Nilsson, A. von Gabain, and S. N. Cohen. 1986. The stability of E. coli gene transcripts is dependent on determinants localized to specific mRNA segments. Cell 46:245-251.[CrossRef][Medline] |
| 8. | Belli, F., A. Capra, A. Moraiti, S. Rossi, and P. Rossi.2000 . Cytokines assay in peripheral blood and bronchoalveolar lavage in the diagnosis and staging of pulmonary granulomatous diseases. Int. J. Immunopathol. Pharmacol. 13:61-67.[Medline] |
| 9. | Bergeron, A., M. Bonay, M. Kambouchner, D. Lecossier, M. Riquet, P. Soler, A. Hance, and A. Tazi. 1997. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159:3034-3043.[Abstract] |
| 10. | Boros, D. L. 1978. Granulomatous inflammations. Prog. Allergy 24:183-267. |
| 11. | Capuano,
S., III, D. A. Croix, S. Pawar, A. Zinovik, A. Myers,
P. L. Lin, S. Bissel, C. Fuhrman, E. Klein, and J.
L. Flynn. 2003. Experimental Mycobacterium
tuberculosis infection of cynomolgus macaques closely resembles
the various manifestations of human M. tuberculosis infection.Infect. Immun.
71:5831-5844. |
| 12. | Chensue, S. W., K. Warmington, J. Ruth, P. Lincoln, M. C. Kuo, and S. L. Kunkel. 1994. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am. J. Pathol. 145:1105-1113.[Abstract] |
| 13. | Chensue, S. W., K. S. Warmington, J. H. Ruth, P. Lincoln, and S. L. Kunkel. 1995. Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF. J. Immunol. 154:5969-5976.[Abstract] |
| 14. | Chiu,
B. C., C. M. Freeman, V. R. Stolberg, E.
Komuniecki, P. M. Lincoln, S. L. Kunkel, and
S. W. Chensue 2003. Cytokine-chemokine
networks in experimental mycobacterial and schistosomal lung granuloma
formation. Am. J. Respir. Cell Mol. Biol.
29:106-116. |
| 15. | Choi,
Y. K., B. A. Fallert, M. A. Murphey-Corb,
and T. A. Reinhart. 2003. Simian
immunodeficiency virus dramatically alters expression of homeostatic
chemokines and dendritic cell markers during infection in vivo.Blood
101:1684-1691. |
| 16. | Cooper,
A. M., D. K. Dalton, T. A. Stewart,
J. P. Griffin, D. G. Russell, and I. M.
Orme. 1993. Disseminated tuberculosis in interferon
gamma gene-disrupted mice. J. Exp. Med.
178:2243-2247. |
| 17. | D'Ambrosio,
D., M. Mariani, P. Panina-Bordignon, and F. Sinigaglia.2001
. Chemokines and their receptors guiding T lymphocyte
recruitment in lung inflammation. Am. J. Respir. Crit.
Care Med.
164:1266-1275. |
| 18. | Dixon,
A. E., J. B. Mandac, D. K. Madtes,
P. J. Martin, and J. G. Clark.2000
. Chemokine expression in Th1 cell-induced lung
injury: prominence of IFN-gamma-inducible chemokines.Am. J. Physiol. Lung Cell Mol. Physiol.
279:L592-L599. |
| 19. | Dye,
C., S. Scheele, P. Dolin, V. Pathania, and M. C.
Raviglione. 1999. Consensus statement. Global burden
of tuberculosis: estimated incidence, prevalence, and mortality by
country. W. H. O. Global Surveillance and
Monitoring Project. JAMA
282:677-686. |
| 20. | Fallert, B. A., and T. A. Reinhart. 2002. Improved detection of simian immunodeficiency virus RNA by in situ hybridization in fixed tissue sections: combined effects of temperatures for tissue fixation and probe hybridization.J. Virol. Methods 99:23-32.[CrossRef][Medline] |
| 21. | Fenhalls,
G., L. Stevens, L. Moses, J. Bezuidenhout, J. C. Betts,
P. P. Helden, P. T. Lukey, and K. Duncan.2002
. In situ detection of Mycobacterium
tuberculosis transcripts in human lung granulomas reveals
differential gene expression in necrotic lesions. Infect.
Immun.
70:6330-6338. |
| 22. | Fenhalls, G., L. Stevens-Muller, R. Warren, N. Carroll, J. Bezuidenhout, P. van Helden, and P. Bardin. 2002. Localisation of mycobacterial DNA and mRNA in human tuberculous granulomas. J. Microbiol. Methods 51:197-208.[CrossRef][Medline] |
| 23. | Fenhalls,
G., A. Wong, J. Bezuidenhout, P. van Helden, P. Bardin, and
P. T. Lukey. 2000. In situ production of
gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA
in human lung tuberculous granulomas. Infect. Immun.
68:2827-2836. |
| 24. | Ferrero, E., P. Biswas, K. Vettoretto, M. Ferrarini, M. Uguccioni, L. Piali, B. E. Leone, B. Moser, C. Rugarli, and R. Pardi.2003 . Macrophages exposed to Mycobacterium tuberculosis release chemokines able to recruit selected leucocyte subpopulations: focus on gamma delta cells. Immunology 108:365-374.[CrossRef][Medline] |
| 25. | Flynn,
J. L., J. Chan, K. J. Triebold,
D. K. Dalton, T. A. Stewart, and B. R.
Bloom. 1993. An essential role for interferon gamma in
resistance to Mycobacterium tuberculosis infection. J.
Exp. Med.
178:2249-2254. |
| 26. | Foxman,
E. F., J. J. Campbell, and E. C.
Butcher. 1997. Multistep navigation and the
combinatorial control of leukocyte chemotaxis. J. Cell
Biol.
139:1349-1360. |
| 27. | Fukunaga,
H., T. Murakami, T. Gondo, K. Sugi, and T. Ishihara.2002
. Sensitivity of acid-fast staining for
Mycobacterium tuberculosis in formalin-fixed tissue.Am. J. Respir. Crit. Care Med.
166:994-997. |
| 28. | Gangur,
V., F. E. Simons, and K. T. Hayglass.1998
. Human IP-10 selectively promotes dominance of
polyclonally activated and environmental antigen-driven IFN-gamma over
IL-4 responses. FASEB J.
12:705-713. |
| 29. | Jouanguy,
E., F. Altare, S. Lamhamedi, P. Revy, J. F. Emile, M.
Newport, M. Levin, S. Blanche, E. Seboun, A. Fischer, and J.
L. Casanova. 1996. Interferon-gamma-receptor
deficiency in an infant with fatal bacille Calmette-Guerin infection.N. Engl. J. Med.
335:1956-1961. |
| 30. | Kaufmann, S. H. 2001. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1:20-30.[CrossRef][Medline] |
| 31. | Kaufmann,
S. H. 2002. Protection against tuberculosis:
cytokines, T cells, and macrophages. Ann. Rheum. Dis.
61(Suppl.
2):ii54-ii58. |
| 32. | Kawahara,
M., T. Nakasone, and M. Honda. 2002. Dynamics of gamma
interferon, interleukin-12 (IL-12), IL-10, and transforming growth
factor beta mRNA expression in primary Mycobacterium bovis BCG
infection in guinea pigs measured by a real-time fluorogenic reverse
transcription-PCR assay. Infect. Immun.
70:6614-6620. |
| 33. | Lande,
R., E. Giacomini, T. Grassi, M. E. Remoli, E. Iona, M.
Miettinen, I. Julkunen, and E. M. Coccia.2003
. IFN-alpha beta released by Mycobacterium
tuberculosis-infected human dendritic cells induces the expression
of CXCL10: selective recruitment of NK and activated T cells.J. Immunol.
170:1174-1182. |
| 34. | Langermans,
J. A., P. Andersen, D. van Soolingen, R. A.
Vervenne, P. A. Frost, T. van der Laan, L. A. van
Pinxteren, J. van den Hombergh, S. Kroon, I. Peekel, S. Florquin, and
A. W. Thomas. 2001. Divergent effect of
bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium
tuberculosis infection in highly related macaque species:
implications for primate models in tuberculosis vaccine research.Proc. Natl. Acad. Sci. USA
98:11497-11502. |
| 35. | Luster,
A. D. 1998. Chemokineschemotactic
cytokines that mediate inflammation. N. Engl.
J. Med.
338:436-445. |
| 36. | Mariano, M. 1995. The experimental granuloma. A hypothesis to explain the persistence of the lesion. Rev. Inst. Med. Trop. Sao Paulo 37:161-176.[Medline] |
| 37. | Means,
T. K., S. Wang, E. Lien, A. Yoshimura, D. T.
Golenbock, and M. J. Fenton. 1999. Human
toll-like receptors mediate cellular activation by Mycobacterium
tuberculosis. J. Immunol.
163:3920-3927. |
| 38. | Murray, P. J. 1999. Defining the requirements for immunological control of mycobacterial infections. Trends Microbiol. 7:366-372.[CrossRef][Medline] |
| 39. | Newport,
M. J., C. M. Huxley, S. Huston, C. M.
Hawrylowicz, B. A. Oostra, R. Williamson, and M. Levin.1996
. A mutation in the interferon-gamma-receptor gene and
susceptibility to mycobacterial infection. N. Engl.
J. Med.
335:1941-1949. |
| 40. | Orme, I. M. 1998. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol. 6:94-97.[CrossRef][Medline] |
| 41. | Orme, I. M., and A. M. Cooper. 1999. Cytokine/chemokine cascades in immunity to tuberculosis.Immunol. Today 20:307-312.[CrossRef][Medline] |
| 42. | Park,
M. K., D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg,
R. L. Rabin, H. H. Zhang, S. Gebeyehu, T.
M. Wright, A. Iwasaki, Y. Weng, J. A. DeMartino,
K. L. Elkins, and J. M. Farber.2002
. The CXC chemokine murine monokine induced by
IFN-gamma (CXC chemokine ligand 9) is made by APCs, targets lymphocytes
including activated B cells, and supports antibody responses to a
bacterial pathogen in vivo. J. Immunol.
169:1433-1443. |
| 43. | Patel, S., M. Yates, and N. A. Saunders. 1997. PCR-enzyme-linked immunosorbent assay and partial rRNA gene sequencing: a rational approach to identifying mycobacteria. J. Clin. Microbiol. 35:2375-2380.[Abstract] |
| 44. | Proost,
P., E. Schutyser, P. Menten, S. Struyf, A. Wuyts, G. Opdenakker, M.
Detheux, M. Parmentier, C. Durinx, A. M. Lambeir, J. Neyts,
S. Liekens, P. C. Maudgal, A. Billiau, and J. Van Damme.2001
. Amino-terminal truncation of CXCR3 agonists impairs
receptor signaling and lymphocyte chemotaxis, while preserving
antiangiogenic properties. Blood
98:3554-3561. |
| 45. | Qiu,
B., K. A. Frait, F. Reich, E. Komuniecki, and S. W.
Chensue. 2001. Chemokine expression dynamics in
mycobacterial (type-1) and schistosomal (type-2) antigen-elicited
pulmonary granuloma formation. Am. J. Pathol.
158:1503-1515. |
| 46. | Reinhart,
T. A., B. A. Fallert, M. E. Pfeifer, S.
Sanghavi, S. Capuano III, P. Rajakumar, M. Murphey-Corb, R. Day,
C. L. Fuller, and T. M. Schaefer.2002
. Increased expression of the inflammatory chemokine
CXC chemokine ligand 9/monokine induced by interferon-gamma in lymphoid
tissues of rhesus macaques during simian immunodeficiency virus
infection and acquired immunodeficiency syndrome. Blood
99:3119-3128. |
| 47. | Rhoades, E. R., A. M. Cooper, and I. M. Orme.1995 . Chemokine response in mice infected with Mycobacterium tuberculosis. Infect. Immun. 63:3871-3877.[Abstract] |
| 48. | Roach,
D. R., A. G. Bean, C. Demangel, M. P.
France, H. Briscoe, and W. J. Britton. 2002.
TNF regulates chemokine induction essential for cell recruitment,
granuloma formation, and clearance of mycobacterial infection.J. Immunol.
168:4620-4627. |
| 49. | Roach,
D. R., H. Briscoe, K. Baumgart, D. A. Rathjen, and
W. J. Britton. 1999. Tumor necrosis factor
(TNF) and a TNF-mimetic peptide modulate the granulomatous response to
Mycobacterium bovis BCG infection in vivo. Infect.
Immun.
67:5473-5476. |
| 50. | Robinson, D. S., S. Ying, I. K. Taylor, A. Wangoo, D. M. Mitchell, A. B. Kay, Q. Hamid, and R. J. Shaw. 1994. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 149:989-993.[Abstract] |
| 51. | Romagnani,
P., F. Annunziato, E. Lazzeri, L. Cosmi, C. Beltrame, L. Lasagni, G.
Galli, M. Francalanci, R. Manetti, F. Marra, V. Vanini, E. Maggi, and
S. Romagnani. 2001. Interferon-inducible protein 10,
monokine induced by interferon gamma, and interferon-inducible T-cell
alpha chemoattractant are produced by thymic epithelial cells and
attract T-cell receptor (TCR) alphabeta+
CD8+ single-positive T cells,
TCRgammadelta+ T cells, and natural killer-type
cells in human thymus. Blood
97:601-607. |
| 52. | Sallusto,
F., D. Lenig, C. R. Mackay, and A. Lanzavecchia.1998
. Flexible programs of chemokine receptor expression
on human polarized T helper 1 and 2 lymphocytes. J. Exp.
Med.
187:875-883. |
| 53. | Saunders, B. M., and A. M. Cooper. 2000. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 78:334-341.[CrossRef][Medline] |
| 54. | Sauty,
A., R. A. Colvin, L. Wagner, S. Rochat, F. Spertini, and
A. D. Luster. 2001. CXCR3 internalization
following T cell-endothelial cell contact: preferential role of
IFN-inducible T cell alpha chemoattractant (CXCL11).J. Immunol.
167:7084-7093. |
| 55. | Somoskovi, A., G. Zissel, P. F. Zipfel, M. W. Ziegenhagen, J. Klaucke, H. Haas, M. Schlaak, and J. Muller-Quernheim.1999 . Different cytokine patterns correlate with the extension of disease in pulmonary tuberculosis. Eur. Cytokine Netw. 10:135-142.[Medline] |
| 56. | Taha, R. A., T. C. Kotsimbos, Y. L. Song, D. Menzies, and Q. Hamid. 1997. IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis.Am. J. Respir. Crit. Care Med. 155:1135-1139.[Abstract] |
| 57. | Taha,
R. A., E. M. Minshall, R. Olivenstein, D. Ihaku, B.
Wallaert, A. Tsicopoulos, A. B. Tonnel, R. Damia, D. Menzies,
and Q. A. Hamid. 1999. Increased expression
of IL-12 receptor mRNA in active pulmonary tuberculosis and
sarcoidosis. Am. J. Respir. Crit. Care Med.
160:1119-1123. |
| 58. | Underhill,
D. M., A. Ozinsky, K. D. Smith, and A. Aderem.1999
. Toll-like receptor-2 mediates mycobacteria-induced
proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci.
USA
96:14459-14463. |
| 59. | van
Crevel, R., T. H. Ottenhoff, and J. W. van der
Meer. 2002. Innate immunity to Mycobacterium
tuberculosis. Clin. Microbiol. Rev.
15:294-309. |
| 60. | Van Damme, J., S. Struyf, A. Wuyts, E. Van Coillie, P. Menten, D. Schols, S. Sozzani, I. De Meester, and P. Proost. 1999. The role of CD26/DPP IV in chemokine processing. Chem. Immunol. 72:42-56.[Medline] |
| 61. | von
Gabain, A., J. G. Belasco, J. L. Schottel,
A. C. Chang, and S. N. Cohen.1983
. Decay of mRNA in Escherichia coli:
investigation of the fate of specific segments of transcripts.Proc. Natl. Acad. Sci. USA
80:653-657. |
| 62. | Walsh, G. P., E. V. Tan, E. C. dela Cruz, R. M. Abalos, L. G. Villahermosa, L. J. Young, R. V. Cellona, J. B. Nazareno, and M. A. Horwitz. 1996. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat. Med. 2:430-436.[CrossRef][Medline] |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||